Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.88 -0.01 (-0.15%)
At close: Nov 11, 2026 · 4:00 PM EST

Cartesian Therapeutics (RNAC) Net Equity Issued and Repurchased (2015 - 2026)

Updated

Cartesian Therapeutics (RNAC) posted Net Equity Issued and Repurchased of $4.31 million for Q2 2026, compared with $85,000 a year earlier and down 72.5% from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Cartesian Therapeutics was $20.04 million, down 84.0% year-over-year; for FY2025, it was $323,000, down 99.8% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -52.8% (FY2020 to FY2025).
  • In prior years, Cartesian Therapeutics' Net Equity Issued and Repurchased was $168.49 million in FY2024 (+722.7%), $20.48 million in FY2023 (-44.9%), $37.2 million in FY2022 and $939,000 in FY2021 (-93.2%).
  • Quarterly Net Equity Issued and Repurchased has run from a low of $5,000 in Q3 2025 to a high of $124.49 million in Q3 2024 over five years.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q3 2022, with growth of 82.4%; the weakest was Q3 2025, with a decline of 100.0%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $15.67 million (Q1 2026), $50,000 (Q4 2025) and $5,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Cartesian Therapeutics 210.06 Mn -304.30 Mn - 3.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.56 Mn
Jun 30, 2026 4.31 Mn
Mar 31, 2026 15.67 Mn
Mar 31, 2025 183,000.00
Dec 31, 2024 849,000.00
Sep 30, 2024 124.49 Mn
Jun 30, 2024 120,000.00
Mar 31, 2024 43.03 Mn
Dec 31, 2023 20.25 Mn
Sep 30, 2023 82,000.00
Mar 31, 2023 149,000.00
Sep 30, 2022 166,000.00
Jun 30, 2022 36.89 Mn
Mar 31, 2022 148,000.00
Dec 31, 2021 104,000.00
Sep 30, 2021 91,000.00
Jun 30, 2021 -20.56 Mn
Mar 31, 2021 21.31 Mn
Dec 31, 2020 63,000.00
Sep 30, 2020 11.27 Mn
API Access

Cartesian Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RNAC&period=max&api_key=YOUR_API_KEY